| Literature DB >> 30233351 |
Yaqi Ding1, Chenqi Xin1, Cheng-Wu Zhang1, Kah-Leong Lim2,3, Hang Zhang1, ZhenQian Fu1, Lin Li1, Wei Huang1.
Abstract
Parkinson's disease (PD) is the second most common neurodegenerative disease after Alzheimer's disease, affecting about 7-10 million patients worldwide. The major pathological features of PD include loss of dopaminergic (DA) neurons in the substantia nigra pars compacta (SNpc) of the midbrain and the presence of α-synuclein-enriched Lewy bodies. Although the mechanism underlying PD pathogenesis remains to be elucidated, oxidative stress induced by the overproduction of reactive oxygen species (ROS) is widely accepted to be a key pathogenic factors. ROS cause oxidative damage to proteins, lipids, and DNA, which subsequently lead to neurodegeneration. Great efforts have been made to slow or stop the progress of PD. Unfortunately there is no effective cure for PD till now. Compounds with good antioxidant activity represent the promising candidates for therapeutics of PD. Some natural molecules from Chinese herbs are found to have good antioxidant activity. Both in vitro and in vivo studies demonstrate that these natural molecules could mitigate the oxidative stress and rescue the neuronal cell death in PD models. In present review, we summarized the reported natural molecules that displayed protective effects in PD. We also addressed the possible signal pathway through which natural molecules achieved their antioxidative effects and mitigate PD phenotypes. Hopefully it will pave the way to better recognize and utilize Chinese herbs for the treatment of PD.Entities:
Keywords: Chinese herb; Parkinson’s disease; dopaminergic neurons; natural molecules; oxidative stress
Year: 2018 PMID: 30233351 PMCID: PMC6127641 DOI: 10.3389/fnagi.2018.00246
Source DB: PubMed Journal: Front Aging Neurosci ISSN: 1663-4365 Impact factor: 5.750
Natural anti-oxidant molecules from Chinese herbs against PD.
| Substances | Studied models | Possible mechanisms | Reference |
|---|---|---|---|
| Epigallocatechin gallate (EGCG) | MPP+-treated PC12 cells | Up-regulates PGC-1α and improves mitochondrial function. | |
| Drosophila with mutant LRRK2 and null parkin | Attenuates mitochondrial-associated pathway in LRRK2 and parkin-related pathogenesis. | ||
| Resveratrol | Primary fibroblast from PD patients with PARK2 mutation | Raises the expression of PGC-1α’s target genes (TFAM, cytochrome c and COX I). | |
| Cordycepin | 6-OHDA-induced PC12 cells | Maintains mitochondrial membrane potential (MMP) and reduce activation of caspase-3. | |
| Baicalein | 6-OHDA-induced SH-SY5Y cells | Attenuates mitochondrial dysfunction, oxidative injury, JNK and caspase activation. | |
| Curcumin | MPP+-induced PC12 cells | Mediates the toxicity of PC12 through Bcl-2-mitochondria-ROS-iNOS pathway. | |
| Chrysotoxine | 6-OHDA-induced SH-SY5Y cells | Attenuates the decrease of MMP, release of cytochrome c, imbalance of Bax/Bcl-2 ratio and activation of caspase-3. | |
| DL-3-n-butylphthalide (NBP) | MPP+-induced PC12 cells | Retains mitochondrial function and suppresses ROS generation. | |
| Mangiferin | Rotenone-induced SK-N-SH cells | Rectifies oxidative imbalance and protects mitochondrial function. | |
| Morin | Excitotoxic neuron with NMDA receptor over-activation | Reduces ROS by restoring the MMP. | |
| Paeonol | MPP+-induced mice | Restores MMP and reduces cytochrome c release and caspase-3 activity. | |
| Ursolic acid | Parkin-mutant fibroblasts | Rescues mitochondrial function by the activation of the glucocorticoid receptor with increased phosphorylation of Akt. | |
| Salidroside | MPP+-induced PC12 cells | Regulates the ratio of Bcl-2/Bax, decrease cytochrome c and Smac release, and inhibit caspase activation. | |
| Asiaticoside | MPTP-induced rats | Attenuates the reduction of GSH level in the substantia nigra. | |
| Polydatin | Rotenone-induced rats | Increases the level of GSH and manganese superoxide dismutases (MnSOD) in the striatum. | |
| Biochanin A | Lipopolysaccharide (LPS)-induced rat | Increases SOD and Gpx activities in the midbrain tissue. | |
| Increases total GSH activities. | |||
| Gypenosides (GP) | MPTP-induced mice | Attenuates the decrease of GSH content and SOD activities in the substantia nigra. | |
| Mangiferin | MPP+-induced N2A cells | Restores the GSH content and down-regulates both SOD1 and CAT mRNA expression. | |
| Nerolidol | Rotenone-induced rats | Increases the level of SOD, CAT, and GSH in midbrain cells. | |
| Quercetin | 6-OHDA-induced rats | Restores the level of GSH in the striatum. | |
| H2O2-induced PC12 cells | Reduces CAT, SOD and Gpx level. | ||
| Kaempferol | MPTP-induced mice | Increases SOD and Gpx activities in the substantia nigra. | |
| Cordycepin | 6-OHDA-induced PC12 cells | Increases SOD and Gpx activities. | |
| Resveratrol | 6-OHDA-induced rats | Up-regulates GPx, GR, CAT, and SOD activities. | |
| Paeonol | MPTP-induced mice | Enhances the levels of SOD, CAT, and GSH. | |
| Gastrodin | MPP+-induced oxidative PD model | Increases antioxidant enzyme HO-1 expression. | |
| Hesperetin | 6-OHDA-lesioned rats | Enhances striatal CAT and GSH content. | |
| Curcumin | MPTP-induced rats | Inhibits MOA-B activity. | |
| Curcumin | 6-OHDA-induced rats | Chelates iron metals in the substantia nigra. | |
| Ginsenoside | 6-OHDA-induced MES23.5 cells | Inhibits up-regulation of an iron importer protein DMT1 with iron IRE. | |
| Myricetin | 6-OHDA-induced rats | Prevents the increase of iron-staining cells in the substantia nigra. | |
| EGCG | Iron-induced SH-SY5Y cells | Alleviates the iron accumulation through affecting IRE. | |
| Naringenin | Iron-induced rats | Chelates iron metals in the cerebral cortex. | |